US Patent Issued to THE ASAN FOUNDATION, EDISBIOTECH, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION on Feb. 18 for "Monoclonal antibody specifically binding to CCSP-2 and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,592, issued on Feb. 18, was assigned to THE ASAN FOUNDATION (Seoul, South Korea), EDISBIOTECH Co. LTD. (Seoul, South Korea) and UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION (Ulsan, South Korea).

"Monoclonal antibody specifically binding to CCSP-2 and use thereof" was invented by Seung-Jae Myung (Seoul, South Korea), Eun-Ju Do (Seoul, South Korea), Jayoung Kang (Buan-gun, South Korea), Hye-Nam Son (Seoul, South Korea), Hyori Kim (Seoul, South Korea), A-Neum Lee (Seoul, South Korea) and Yeong Hui Cho (Hanam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a monoclonal antibody which specificall...